AZN · Astrazeneca PLC
Market Cap
$252.33B
Shares
1.55B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-08-27 | — | |
| 6-K | 2026-08-25 | — | |
| 6-K | 2026-08-19 | — | |
| 6-K | 2026-08-17 | — | |
| 6-K | 2026-08-17 | — | |
| 6-K | 2026-08-17 | — | |
| 6-K | 2026-08-03 | — | |
| 6-K | 2026-08-03 | — | |
| 6-K | 2026-07-31 | — | |
| 6-K | 2026-07-27 | 2026-06-30 | |
| 6-K | 2026-07-27 | — | |
| 6-K | 2026-07-27 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-29 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-28 | — | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-21 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-09 | — | |
| 6-K | 2026-04-02 | — | |
| 6-K | 2026-04-01 | — |
Showing 1–50 of 740 filings